You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

TROVAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Trovan patents expire, and what generic alternatives are available?

Trovan is a drug marketed by Pfizer and is included in three NDAs.

The generic ingredient in TROVAN is azithromycin dihydrate; trovafloxacin mesylate. There are thirty-two drug master file entries for this compound. Additional details are available on the azithromycin dihydrate; trovafloxacin mesylate profile page.

US Patents and Regulatory Information for TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer TROVAN PRESERVATIVE FREE alatrofloxacin mesylate INJECTABLE;INJECTION 020760-002 Dec 18, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer TROVAN PRESERVATIVE FREE alatrofloxacin mesylate INJECTABLE;INJECTION 020760-001 Dec 18, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer TROVAN/ZITHROMAX COMPLIANCE PAK azithromycin dihydrate; trovafloxacin mesylate FOR SUSPENSION, TABLET;ORAL 050762-001 Dec 18, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TROVAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 ⤷  Try a Trial ⤷  Try a Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 ⤷  Try a Trial ⤷  Try a Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-001 Dec 18, 1997 ⤷  Try a Trial ⤷  Try a Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 ⤷  Try a Trial ⤷  Try a Trial
Pfizer TROVAN trovafloxacin mesylate TABLET;ORAL 020759-002 Dec 18, 1997 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TROVAN

See the table below for patents covering TROVAN around the world.

Country Patent Number Title Estimated Expiration
German Democratic Republic 298399 AZABICYCLO-CHINOLON-CARBONSAEUREN ⤷  Try a Trial
Hungary 219403 Azabiciklo-csoporttal helyettesített kinolon- �xe9;s naftiridon-karbonsavak és eljárás ezek előállítására (AZABICYCLO-SUBSTITUTED QUINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACIDS AND PROCESS FOR PRODUCING THEM) ⤷  Try a Trial
Denmark 0413455 ⤷  Try a Trial
Slovakia 4299 A TABLET CONTANING METHANESULFONATE OF TROVAFLOXACIN ⤷  Try a Trial
European Patent Office 0930068 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for TROVAN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0413455 SPC/GB98/045 United Kingdom ⤷  Try a Trial PRODUCT NAME: TROVAFLOXACIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR THE MESYLATE SALT.; REGISTERED: CH 54483 19980327; UK EU/1/98/059/001 19980703; UK EU/1/98/059/002 19980703; UK EU/1/98/059/003 19980703; UK EU/1/98/059/004 19980703; UK EU/1/98/059/005 19980703; UK EU/1/98/059/006 19980703; UK EU/1/98/059/007 19980703; UK EU/1/98/059/008 19980703; UK EU/1/98/059/009 19980703; UK EU/1/98/059/010 19980703; UK EU/1/98/059/011 19980703; UK EU/1/98/059/012 19980703
0413455 98C0040 Belgium ⤷  Try a Trial PRODUCT NAME: ALATROFLOXACIN; NAT. REGISTRATION NO/DATE: EU/1/98/060/001 19980327; FIRST REGISTRATION: CH 54484 19980327
0413455 SPC/GB98/046 United Kingdom ⤷  Try a Trial PRODUCT NAME: ALATROVAFLOXACIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR THE MESYLATE SALT.; REGISTERED: CH 54484 19980327; UK EU/1/98/060/001 19980703; UK EU/1/98/060/002 19980703; UK EU/1/98/060/003 19980703
0413455 98C0039 Belgium ⤷  Try a Trial PRODUCT NAME: TROVAFLOXACIN; NAT. REGISTRATION NO/DATE: EU/1/98/059/001 19980703; FIRST REGISTRATION: CH 54483 19980327
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.